Azitra, Inc.
corporate_fare Company Profile
Azitra, Inc. (NYSE:AZTR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for AZTR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 2 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above. Recent SEC coverage for AZTR spans SCHEDULE 13D, 10-Q.
Recent high-impact activity:
- Young Pharmaceuticals Discloses 5.22% Azitra Stake, Plans Board Engagement
- Azitra Q3 10-Q: Going-Concern Doubt, $3.75M Cash, Equity Below NYSE American Minimum
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 305,802 shares in AZTR as of the October 30, 2026 settlement, a 172.3% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 16, 2026, 82.9% of AZTR volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.